Ansilo HealthAnsilo Health

News & Insights

News & Insights

Company announcements, thought leadership, and industry insights from the Ansilo team.

AnnouncementsJune 2026

Ansilo Health Announces a Seed Funding Round: The Founder's Circle

Ansilo Health is pleased to announce a Seed Funding Round, known as the Founder's Circle, which closes at 18:00 (GMT+2) on Tuesday, 23 June 2026. Ansilo Health has taken the decision to limit the Founder's Circle to invitation-only participation.

Thought LeadershipJune 2026

Building Pharmaceutical Capability in Africa: A Strategic Imperative

Africa imports over 70% of its medicines. With major patent expiries approaching and multinational portfolios being rationalised, the case for local pharmaceutical capability has never been stronger.

Thought LeadershipJune 2026

AI and the Pharmaceutical Sales Representative

Artificial intelligence will transform pharmaceutical sales, but not by replacing representatives. The future belongs to professionals who combine AI tools with human relationships and scientific depth.

Industry InsightsJune 2026

The Role of Quality Systems in Pharmaceutical Credibility

For an emerging pharmaceutical company, quality systems are not a regulatory afterthought. They are the foundation of institutional credibility, partner trust, and long-term viability.

Thought LeadershipMay 2026

Dr Michael Klein: Why I'm Building Ansilo Health

A personal reflection from Ansilo's founder on the vision, the opportunity, and the commitment required to build one of Africa's most important pharmaceutical companies.

Industry InsightsJune 2026

Understanding SAHPRA Compliance for Pharmaceutical Companies

A practical overview of SAHPRA regulatory requirements for pharmaceutical companies operating in South Africa, including dossier submission, GMP compliance, and pharmacovigilance.

Stay Updated

Subscribe to receive Ansilo Health news, insights, and announcements directly to your inbox.

Looking for press resources, media contacts, or brand assets?

Visit Media Centre